SAN DIEGO--(BUSINESS WIRE)--Endeavor BioMedicines (“Endeavor”), a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients ...
Amarin (AMRN) highlighted a new post hoc analysis of aspirin use in REDUCE-IT reinforcing that icosapent ethyl significantly reduced cardiovascular events in high-risk patients. These findings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback